Content about New Brunswick

NEW BRUNSWICK, N.J. — Johnson & Johnson chairman and CEO Alex Gorsky last week told shareholders that its consumer healthcare business would reclaim its prominence in the U.S. marketplace at the company's annual shareholder meeting. But OTC growth will be greatest outside of the United States.

NEW BRUNSWICK, N.J. — Johnson & Johnson expects to return about 75% of its OTC brands to the marketplace over the course of 2013, Alex Gorsky, J&J chairman and CEO told analysts Tuesday. "I’m very pleased with the progress that we’re making in that," he said. "We mentioned to you that the consent decree that we had designed in conjunction with the FDA was approved and reviewed in October, with very few comments. And given the breadth and scale of that agreement, we felt very good about that. We’ve had teams working hard since then.

DEERFIELD, Ill. — Walgreens on Wednesday pledged $250,000 to the American Red Cross Disaster Relief Fund to supplement the organization's support of East Coast communities recovering from Hurricane Sandy.

The company also is donating three semitrailer truckloads of bottled water to a Red Cross facility in New Brunswick, N.J., to distribute throughout the disaster area. Walgreens stores in the region also are donating merchandise in response to community requests that have come in since the storm’s impact.

NEW BRUNSWICK, N.J. — Johnson & Johnson Consumer earlier this summer put the freeze on pain with the launch of its Bengay Zero Degrees line extension, an external analgesic rub that makes its home alongside the frozen peas in the freezer. According to the company, it’s the first and only topical pain reliever that can be stored in the freezer. Sales of the Bengay brand were up 6.4% to $8.9 million for the 12 weeks ended July 8 across food, drug and mass (excluding Walmart), according to SymphonyIRI Group data.

NEW BRUNSWICK, N.J. — Johnson & Johnson Consumer Cos. last week voluntarily recalled from retailers one lot of Aveeno Baby Calming Comfort lotion that was distributed in Alabama, Arkansas, Florida, Georgia, Kansas, Louisiana, Mississippi, Tennessee and Texas.

This is not a consumer level recall and no action is required by consumers, the company stated.

In the Feb. 7, 2011, issue, Drug Store News named three major issues that would define 2011 for the world of generic drugs. Those issues were drug safety, generic user fees and patent settlements.

NEW BRUNSWICK, N.J. — Johnson & Johnson Tuesday morning pledged significant support behind the relaunch of several McNeil Consumer products into the marketplace in 2012, and feels confident impacted brands — Tylenol and Motrin, among others — will be able to recapture market share, despite significant private-label erosion.

NEW BRUNSWICK, N.J. — Johnson & Johnson on Thursday announced that the company has entered into an agreement to become a global sponsor of the 2014 FIFA World Cup Brazil, becoming the eighth and final FIFA World Cup sponsor.

With this sponsorship, Johnson & Johnson will be the exclusive and official healthcare sponsor, with the ability to promote across their consumer, medical devices and diagnostics, and pharmaceutical businesses.

NEW BRUNSWICK, N.J. — Johnson & Johnson on Tuesday announced that distribution of McNeil Consumer Healthcare consumer products will slow in the coming months as the company shifts production of its over-the-counter medicines to other manufacturing plants and implements additional third-party quality controls within those plants.

NEW BRUNSWICK, N.J. — Johnson & Johnson posted decreases in sales for fourth quarter 2010 and for the year, according to an earnings statement released Tuesday.

Sales for the quarter were $15.6 billion, a 5.5% decrease from fourth quarter 2009’s $16.5 billion. Sales for the year were $61.6 billion, down by 0.5% from $61.9 billion in 2009.

Meanwhile, profits for the quarter were $1.9 billion, a 12% decrease from $2.2 billion in fourth quarter 2009. Profits for the year were $13.3 billion, an 8.7% increase over $12.3 billion in 2009.

NEW BRUNSWICK, N.J. — Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.

Both appointments are effective Jan. 3.

NEW BRUNSWICK, N.J. Johnson & Johnson is recalling millions of packages of over-the-counter drugs for allergies and pain due to manufacturing problems, according to published reports.

The New York Times reported Tuesday that J&J would recall 4 million packages of cherry- and grape-flavored Children’s Benadryl (diphenhydramine) tablets for allergies and 800,000 bottles of children’s Motrin (ibuprofen), a pain drug.